David E. Kelley,Ping Liu,Harold B. Wood,Scott D. Edmondson,Hideo Makimura,Xiaoyan Li,Timothy Joseph Kowalski
申请号：
US15780462
公开号：
US20180353507A1
申请日:
2016.12.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Use of a GPR119 agonist in the prevention or treatment of hypoglycemia is disclosed, addition, pharmaceutical compositions and combinations of a GPR1 19 agonist with insulin, insulin analog, insulin secretagogue or or other drug(s) that reduces plasma glucose levels to below 70 mg/dL described herein.
